Certified by Founder Lodge
NRG Therapeutics
United Kingdom - Stevenage, Hertfordshire
START UP
1 Disclosed Funding Rounds $67,835,242
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mitochondrial therapeutics for the treatment of neurodegenerative diseases
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 09 ,2025 | Series B | $67,835,242 |
Omega Funds
British Business Bank
Brandon Capital
Criteria Bio Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Latent | $80,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Avtal | $24,000,000 | (Mar 20, 2026)
